Strategy Asset Managers’s Boston Scientific BSX Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $2.12M | Sell |
19,716
-109
| -0.5% | -$11.7K | 0.4% | 58 |
|
|
2025
Q1 | $2M | Buy |
19,825
+399
| +2% | +$40.3K | 0.41% | 59 |
|
|
2024
Q4 | $1.74M | Sell |
19,426
-814
| -4% | -$72.7K | 0.34% | 62 |
|
|
2024
Q3 | $1.7M | Buy |
20,240
+12,265
| +154% | +$1.03M | 0.33% | 62 |
|
|
2024
Q2 | $431K | Sell |
7,975
-2,464
| -24% | -$133K | 0.1% | 147 |
|
|
2024
Q1 | $715K | Buy |
10,439
+1,605
| +18% | +$110K | 0.15% | 109 |
|
|
2023
Q4 | $511K | Buy |
8,834
+153
| +2% | +$8.85K | 0.12% | 126 |
|
|
2023
Q3 | $458K | Buy |
8,681
+706
| +9% | +$37.3K | 0.12% | 132 |
|
|
2023
Q2 | $431K | Sell |
7,975
-187
| -2% | -$10.1K | 0.1% | 147 |
|
|
2023
Q1 | $408K | Buy |
8,162
+331
| +4% | +$16.6K | 0.1% | 143 |
|
|
2022
Q4 | $362K | Sell |
7,831
-54
| -0.7% | -$2.5K | 0.09% | 162 |
|
|
2022
Q3 | $305K | Buy |
+7,885
| New | +$305K | 0.08% | 172 |
|
|
2022
Q1 | – | Sell |
-8,108
| Closed | -$344K | – | 255 |
|
|
2021
Q4 | $344K | Buy |
+8,108
| New | +$344K | 0.09% | 143 |
|
|
2019
Q2 | – | Sell |
-480
| Closed | -$18K | – | 132 |
|
|
2019
Q1 | $18K | Sell |
480
-48,383
| -99% | -$1.81M | ﹤0.01% | 178 |
|
|
2018
Q4 | $1.73M | Sell |
48,863
-43,191
| -47% | -$1.53M | 0.42% | 60 |
|
|
2018
Q3 | $3.54M | Buy |
+92,054
| New | +$3.54M | 0.72% | 34 |
|
|
2016
Q4 | – | Sell |
-104,095
| Closed | -$2.48M | – | 129 |
|
|
2016
Q3 | $2.48M | Buy |
+104,095
| New | +$2.48M | 0.56% | 64 |
|
|
2016
Q1 | – | Sell |
-131,461
| Closed | -$2.42M | – | 143 |
|
|
2015
Q4 | $2.42M | Buy |
131,461
+281
| +0.2% | +$5.18K | 0.55% | 61 |
|
|
2015
Q3 | $2.15M | Buy |
+131,180
| New | +$2.15M | 0.52% | 64 |
|